Hannah Valantine - Net Worth and Insider Trading

Hannah Valantine Net Worth

The estimated net worth of Hannah Valantine is at least $49,145 dollars as of 2024-06-15. Hannah Valantine is the Director of BridgeBio Pharma Inc and owns about 1,764 shares of BridgeBio Pharma Inc (BBIO) stock worth over $49,145. Details can be seen in Hannah Valantine's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hannah Valantine has not made any transactions after 2024-01-16 and currently still holds the listed stock(s).

Transaction Summary of Hannah Valantine

To

Hannah Valantine Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Hannah Valantine owns 3 companies in total, including CareDx Inc (CDNA) , Pacific Biosciences of California Inc (PACB) , and BridgeBio Pharma Inc (BBIO) .

Click here to see the complete history of Hannah Valantine’s form 4 insider trades.

Insider Ownership Summary of Hannah Valantine

Ticker Comapny Transaction Date Type of Owner
CDNA CareDx Inc 2021-07-01 director
PACB Pacific Biosciences of California Inc 2021-06-16 director
BBIO BridgeBio Pharma Inc 2024-01-16 director

Hannah Valantine Latest Holdings Summary

Hannah Valantine currently owns a total of 1 stock. Hannah Valantine owns 1,764 shares of BridgeBio Pharma Inc (BBIO) as of January 16, 2024, with a value of $49,145.

Latest Holdings of Hannah Valantine

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BBIO BridgeBio Pharma Inc 2024-01-16 1,764 27.86 49,145

Holding Weightings of Hannah Valantine


Hannah Valantine Form 4 Trading Tracker

According to the SEC Form 4 filings, Hannah Valantine has made a total of 4 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 2,915 shares on January 16, 2024, which brought Hannah Valantine around $110,683.

Insider Trading History of Hannah Valantine

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Hannah Valantine Trading Performance

GuruFocus tracks the stock performance after each of Hannah Valantine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hannah Valantine is -23.47%. GuruFocus also compares Hannah Valantine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hannah Valantine within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Hannah Valantine's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Hannah Valantine

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -36.29 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -28.75 LIMIT LIMIT LIMIT LIMIT LIMIT

Hannah Valantine Ownership Network

Ownership Network List of Hannah Valantine

No Data

Ownership Network Relation of Hannah Valantine

Insider Network Chart

Hannah Valantine Owned Company Details

What does CareDx Inc do?

Who are the key executives at CareDx Inc?

Hannah Valantine is the director of CareDx Inc. Other key executives at CareDx Inc include See Remarks Reginald Seeto , director & President and CEO Peter Maag , and See Remarks Abraham Ronai .

CareDx Inc (CDNA) Insider Trades Summary

Over the past 18 months, Hannah Valantine made no insider transaction in CareDx Inc (CDNA). Other recent insider transactions involving CareDx Inc (CDNA) include a net sale of 70,941 shares made by Reginald Seeto , and a net sale of 15,701 shares made by Peter Maag .

In summary, during the past 3 months, insiders sold 0 shares of CareDx Inc (CDNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 86,642 shares of CareDx Inc (CDNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 86,642 shares.

CareDx Inc (CDNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

CareDx Inc Insider Transactions

No Available Data

Hannah Valantine Mailing Address

Above is the net worth, insider trading, and ownership report for Hannah Valantine. You might contact Hannah Valantine via mailing address: 1305 O'brien Drive, Menlo Park Ca 94025.

Discussions on Hannah Valantine

No discussions yet.